BE855236A - Derives omega-nor-aromatiques de 13,14-dehydro-prostaglandines et procede pour leur preparation - Google Patents

Derives omega-nor-aromatiques de 13,14-dehydro-prostaglandines et procede pour leur preparation

Info

Publication number
BE855236A
BE855236A BE178071A BE178071A BE855236A BE 855236 A BE855236 A BE 855236A BE 178071 A BE178071 A BE 178071A BE 178071 A BE178071 A BE 178071A BE 855236 A BE855236 A BE 855236A
Authority
BE
Belgium
Prior art keywords
dehydro
omega
aromatic
preparation
prostaglandin derivatives
Prior art date
Application number
BE178071A
Other languages
English (en)
French (fr)
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2382676A external-priority patent/IT1060884B/it
Priority claimed from IT3045876A external-priority patent/IT1065450B/it
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of BE855236A publication Critical patent/BE855236A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
BE178071A 1976-06-01 1977-05-31 Derives omega-nor-aromatiques de 13,14-dehydro-prostaglandines et procede pour leur preparation BE855236A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2382676A IT1060884B (it) 1976-06-01 1976-06-01 Aromatiche prostaglandine
IT3045876A IT1065450B (it) 1976-12-16 1976-12-16 Oxaprostaglandine

Publications (1)

Publication Number Publication Date
BE855236A true BE855236A (fr) 1977-11-30

Family

ID=26328426

Family Applications (1)

Application Number Title Priority Date Filing Date
BE178071A BE855236A (fr) 1976-06-01 1977-05-31 Derives omega-nor-aromatiques de 13,14-dehydro-prostaglandines et procede pour leur preparation

Country Status (18)

Country Link
US (1) US4195183A (xx)
JP (1) JPS52148044A (xx)
AT (2) AT356302B (xx)
AU (1) AU509127B2 (xx)
BE (1) BE855236A (xx)
CA (1) CA1115700A (xx)
CH (1) CH634831A5 (xx)
CS (1) CS192484B2 (xx)
DE (1) DE2721534A1 (xx)
DK (1) DK233377A (xx)
FR (1) FR2368473A1 (xx)
GB (1) GB1583263A (xx)
HU (1) HU181424B (xx)
IL (1) IL51877A (xx)
NL (1) NL7705701A (xx)
NZ (1) NZ184187A (xx)
SE (1) SE436026B (xx)
SU (1) SU932985A3 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH656877A5 (de) * 1981-11-27 1986-07-31 Erba Farmitalia Optisch aktive oder racemische prostaglandinderivate.
US5972991A (en) 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
WO2003074481A2 (en) * 2002-03-01 2003-09-12 Allergan, Inc. Preparation of prostamides
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
WO2010102078A1 (en) 2009-03-04 2010-09-10 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
WO2011046569A1 (en) * 2009-10-16 2011-04-21 Cayman Chemical Company Process for the preparation of f-series prostaglandins
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
JP2020034682A (ja) 2018-08-29 2020-03-05 キオクシア株式会社 露光方法、露光制御装置および半導体装置の製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU501803B2 (en) * 1975-03-21 1979-06-28 Farmitalia Carlo Erba S.P.A. Fluoro-prostaglandins
ZA765031B (en) * 1975-09-10 1977-10-26 Univ Chicago Fluorinated prostaglandins and related compounds and chemical process

Also Published As

Publication number Publication date
AU2465677A (en) 1978-11-02
GB1583263A (en) 1981-01-21
AT367747B (de) 1982-07-26
CA1115700A (en) 1982-01-05
FR2368473A1 (fr) 1978-05-19
AU509127B2 (en) 1980-04-24
CH634831A5 (en) 1983-02-28
HU181424B (en) 1983-07-28
US4195183A (en) 1980-03-25
SE7706310L (sv) 1977-12-02
ATA333477A (de) 1979-09-15
DE2721534A1 (de) 1977-12-15
SU932985A3 (ru) 1982-05-30
DK233377A (da) 1977-12-02
CS192484B2 (en) 1979-08-31
NL7705701A (nl) 1977-12-05
JPS52148044A (en) 1977-12-08
ATA383179A (de) 1981-12-15
NZ184187A (en) 1978-07-28
JPS6140662B2 (xx) 1986-09-10
IL51877A (en) 1981-09-13
IL51877A0 (en) 1977-06-30
FR2368473B1 (xx) 1981-09-11
SE436026B (sv) 1984-11-05
AT356302B (de) 1980-04-25

Similar Documents

Publication Publication Date Title
BE849794A (fr) Derives de carbostyrile et leur procede de preparation
FR2315930A1 (fr) Derives de 1,4-dihydropyridine et leur procede de preparation
BE850401A (fr) Derives de phtalane et procede de preparation
FR2349603A1 (fr) Acrylamide-amidons et procede pour leur preparation
FR2349579A1 (fr) Derives de 1,2-dihydronaphtalene et leur procede de preparation
BE862578A (fr) Electrocatalyseurs et procede pour leur preparation
BE856725A (fr) Derives peptidiques et procede pour leur preparation
BE855236A (fr) Derives omega-nor-aromatiques de 13,14-dehydro-prostaglandines et procede pour leur preparation
RO79048A (ro) Procedeu pentru prepararea unor derivati de 5,11-dihidro-6h-pirido-(2,3b)-(1,4)-benzodiazepin-6-ona
BE856220A (fr) Polyether-polyureides et procede de leur preparation
RO76588A (ro) Procedeu pentru prepararea unor derivati de 1,3,4,tiadiazol
BE856973A (fr) Derives peptidiques et procede pour leur preparation
BE851681A (fr) 2,9-dioxatricyclo-4,3,03,7- decanes et procede pour leur preparation
FR2353537A1 (fr) Nouveaux derives aminomethylazoliques, leur procede de preparation et l
BE844229A (fr) Nouveaux derives d'apovincaminol leur procede de preparation et leur application
FR2346337A1 (fr) Derives d'uracil, leur procede de preparation et leur application pharmacologique
FR2336362A1 (fr) 1,1-dihalogeno-4-methyl-1,3-pentadienes et procede pour leur obtention
FR2321885A1 (fr) Derives du vincane substitues en position 14, et leur procede de preparation
BE855121A (fr) Derives d'uracile et procede pour leur preparation
BE848627A (fr) Derives substitues d'aminobenzaldehydes et leur procede de preparation,
BE856724A (fr) Derives peptidiques et procede pour leur preparation
FR2349575A1 (fr) Derives d'indazole et procede pour leur preparation
FR2352830A1 (fr) Derives de la neamine et leur procede de preparation
BE843576A (fr) Derives de 1,4-dihydropyridine et leur procede de preparation
BE862066A (fr) Agents anti-rhinovirus et procede de leur preparation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: CARLO ERBA S.P.A.

Effective date: 19880531